Bullfinch AG: Bullfinch AG and Aquila Capital launch Joint Investment Vehicle for energy-efficient assets
(Frankfurt, Germany): Aquila Capital and bullfinch are pleased to announce the launch of a strategic joint investment vehicle intended to invest in energy efficiency assets across Europe. By combining Aquila Capital’s leading investment experience in real assets and renewable energy, with bullfinch’s unique expertise in decentralized renewable projects and next-gen technology platform, the partnership intends to make an immediate impact in the renewable investment landscape.
With more than EUR 25 trillion to be invested in upgrading real estate assets across Europe to achieve climate goals, decentralized green infrastructure projects play an increasingly critical role in fighting climate change. The joint investment vehicle aims to become a relevant pure player in energy efficiency, targeting an investment of more than EUR 200 million in the next two years.
Aquila and bullfinch’s initiative will support the fast expansion of digital smart metering through financing, asset acquisition, and operations. Ultimately, Aquila and bullfinch are working together to realize the common vision of a world entirely powered by clean energy.
Bullfinch AG
Bullfinch AG, based in Frankfurt am Main, was founded in 2019 by CEO Robin Haack. The company is committed to a world powered by renewable energy: The Clean-Energy-as-a-Service technology platform enables the bundling, financing, standardization and management of sustainable building and facility infrastructure to make this vision a reality. Bullfinch's solutions span four verticals: Power Generation, Clean Mobility, Energy Storage and Smart Buildings. Through partnerships with institutional investors and innovative energy hardware providers, they bridge the gap between capital and opportunity, enabling the accelerated global transition to clean energy.
Contacts
Bullfinch AG
Lucas Neurauter c/o BETTERTRUST GmbH, Luisenstraße 40, 10117 Berlin
Tel: (+49) 30 / 340 60 10 - 93, Mobil: (+49) 0176 / 619 111 76,
l.neurauter@bettertrust.de
About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release
Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized
Dr. Stefanie Kesting appointed as CEO of Thyssengas7.1.2026 14:06:26 CET | Press release
Dortmund, 06.01.2026 As of January 1, 2026, Dr. Stefanie Kesting has been appointed as the new Chief Executive Officer (CEO) of Thyssengas GmbH. She succeeds Dr. Thomas Gößmann, who will retire at the end of February 2026 after nearly nine years at the helm of the company. The leadership transition was announced in autumn 2025.
30 Years of European Spas: Nature, Natural Remedies and Climate Health as Europe’s Unique Strength7.1.2026 08:59:31 CET | Press release
To mark its 30th anniversary, the European Spas Association (ESPA) has released a special commemorative publication highlighting the strategic role of Europe’s medical spas and climate-health resorts in an era defined by prevention, longevity and sustainable wellbeing.
Forum for a self-reliant and self-determined Europe - the "Sovereign Europe Forum"23.12.2025 08:40:47 CET | Press release
Entrepreneurs, top managers and leaders from United Europe e.V. and European Forum Alpbach (EFA) are founding the Sovereign Europe Forum i.G.
Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release
youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom